^
Association details:
Biomarker:OXCT1 expression
Cancer:Bladder Cancer
Drug:gemcitabine (DNA synthesis inhibitor)
Direction:Resistant
Evidence:
Evidence Level:
Resistant: D – Preclinical
Source:
Title:

3239 / 8 - OXCT1: Role of ketone bodies in acquired gemcitabine resistance in bladder cancer

Published date:
03/09/2022
Excerpt:
We measured the expression of OXCT1 in RT4, UMUC3, T24 and 5637 bladder cancer cell lines and observed that expression correlated with gemcitabine resistance.